February 25, 2013

Why Are Cancer Drugs So Expensive per MD Anderson Oncologists


Why are cancer drugs so expensive per MD Anderson oncologists.
 


Hagop Kantarjian and others 
We believe that the price of cancer drugs is too high. Those already-high prices, which continue to rise rapidly, are an increasingly significant issue in U.S. health-care expenditures. The average monthly price of cancer drugs has doubled over the past 10 years, from about $5,000 to more than $10,000. Of the 12 new cancer drugs approved by the Food and Drug Administration last year, 11 were priced above $100,000 annually. Yet only three were found to improve patient survival rates and, of these, two increased survival by less than two months.

To paraphrase the causes listed for high-prices
  • Pharma companies and hospitals price drugs to what patients can bear to the extreme
  • If patients and insurance companies cannot negotiate the prices, too bad.
    They are liable for the higher prices.
  • Pay to Delay – pharma companies paying generic drug makers to keep cheaper generics off the market.
    e.g. Bayer Nexavar normally costs $5,500/month. A generic Nexavar is available for $175/month in India.

MD Anderson doctors are rightly concerned about the high prices for drugs.

But MD Anderson is also part of the problem. As mentioned in Hospital chargemaster, why are medical bills so high, MD Anderson adds its huge margin on top of the pharma drug prices. And MD Anderson is very hard-nosed about getting patients to pay.

The root cause is again the infamous, mysterious Hospital chargemaster.


Tags: MD Anderson oncologist, why are cancer drugs so expensive, reason for high drug prices, bayer nexavar price, high cancer drug prices per MD Anderson, MD Anderson chargemaster, Hagop Kantarjian, Tito Fojo, Leonard Zwelling